Contrast-associated acute kidney injury and cardiovascular events: a secondary analysis of the PRESERVE cohort.

"CONFLICT OF INTEREST STATEMENT R.M. reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases and consulting fees from Baxter Inc unrelated to this study. P.M.P. received consulting fees and advisory committee fees from Durect, Health-Span Dx, and Novartis; served on a Data and Safety Monitoring Board for Baxter; served as a member of an endpoint adjudication committee for GE Healthcare; and reports receiving grants from BioPorto and Dascena outside the submitted work. S.W. has received consulting fees and advisory fees from Durect and Saghmos Therapeutics and reports receiving personal fees from Cytokinetics and Saghmos Therapeutics outside the submitted work. J.A.K. has received grant support and/or consulting fees from Astute Medical/BioMerieux, and GE Healthcare outside the submitted work. M. Kelly has nothing to disclose."

"FUNDING This study was supported by the United States Department of Veterans Affairs Office of Research and Development grant VA CSP #578 PRESERVE Trial (Principal Investigators: S.W.; co-Principal Investigator: P.M.P.), National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK098214 Biomarker Collection and Analysis in the PRESERVE Trial Cohort (Multiple Principal Investigators: S.W., P.M.P., C.R. Parikh), and National Institute of Diabetes, and Digestive, and Kidney Diseases award 5R01DK106256 (Principal Investigator: R.M.)."